Person

Richard R. Deluca

EVP&Pres, Merck Animal Heallth, Merck & Co.

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$71.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 12, 2026MRKSale11,099$131.61$1.5M
Aug 12, 2026MRKSale600$132.04$79K
Aug 11, 2026MRKSale7,410$131.33$973K
Aug 11, 2026MRKSale5,427$132.35$718K
Aug 10, 2026MRKSale20,784$130.43$2.7M
Aug 6, 2026MRKSale805$131.02$105K
Aug 6, 2026MRKSale300$131.02$39K
Aug 6, 2026MRKSale4,945$130.23$644K
Feb 6, 2026MRKSale37,685$120.92$4.6M
Nov 8, 2023MRKSale43,823$105.03$4.6M
May 1, 2023MRKSale75,436$116.03$8.8M
Apr 28, 2023MRKSale66,163$115.00$7.6M
Oct 28, 2022MRKSale164,557$100.26$16.5M
Nov 4, 2021MRKSale29,782$90.40$2.7M
Oct 29, 2021MRKSale135,405$87.56$11.9M
Aug 9, 2019MRKSale6,427$85.09$547K
Aug 8, 2019MRKSale31,699$85.01$2.7M
May 3, 2019MRKSale35,000$80.00$2.8M
Oct 30, 2018MRKSale25,467$72.00$1.8M

SEC reporting-owner ID (CIK) 1421339 · all filings on EDGAR